Lifecore Biomedical (LFCR) PT Raised to $10 at Craig-Hallum
Tweet Send to a Friend
Craig-Hallum analyst Matt Hewitt raised the price target on Lifecore Biomedical (NASDAQ: LFCR) to $10.00 (from $8.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
